Drawing for EGRET

USPTO serial 87871341

EGRET

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MIDDLETON, BERNICE L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EGRET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

BARBARA J. GRAHN

BARBARA J. GRAHN FOX ROTHSCHILD LLP222 SOUTH NINTH STSUITE 2000MINNEAPOLIS, MN 55402

Goods and services

ClassDescriptionStatusFirst use
035Business and management consulting for healthcare providers and related businesses; business data analysis and reporting in the field of healthcare, health and wellness, health assessment and risk management in the field of healthcare; consulting in the fields of healthcare operations management, hospital operations management, and long-term care facilities operation management; business assistance services, namely, assisting health care facilities, healthcare providers and other related businesses with continuity of care, risk assessment, resource allocation, client and patient follow-up, and client and patient monitoring to improve healthcare outcomes and satisfaction and to improve healthcare across a continuum of care and through transitions in careACTIVE—
042Providing temporary use of non-downloadable software for recording, storing, tracking, analyzing, and reporting patient information in the field of healthcare, health and wellness, health assessment and risk management in the field of healthcare; providing an interactive website or other interface, namely, computer network interfaces, human-machine interfaces, virtual computer systems and environments, multi-platform interfaces, audio interfaces, visual interfaces, or access to computers, tablets, mobile devices or mobile applications, featuring methods and technology that enable users to enter, access, track, monitor, and analyze health and medical information and generate health and medical information reports; providing an interactive website or other interface, namely, computer network interfaces, human-machine interfaces, virtual computer systems and environments, multi-platform interfaces, audio interfaces, visual interfaces, or access to computers, tablets, mobile devices or mobile applications, featuring methods and technology that enable physicians, medical groups, long-term and short-term care providers, home care providers, assisted living facilities, clinics, hospitals and other healthcare providers in providing longitudinal health risk assessment by allowing users to track, aggregate, monitor, analyze and report patient health and healthcare data from different sources for purposes of assessing, monitoring and managing patient health, wellness and health risk across a continuum of care and through transitions in care and progression of health risk; providing an interactive website or other interface, namely, computer network interfaces, human-machine interfaces, virtual computer systems and environments, multi-platform interfaces, audio interfaces, visual interfaces, or access to computers, tablets, mobile devices or mobile applications, featuring methods and technology that enable users to track patient-specific risk adjustment information, assess provider performance, and predict successful resource dedication and partnership design for healthcare stakeholders such as physicians, medical groups, long-term and short-term care providers, home care providers, assisted living facilities, clinics, hospitals, payors, health plan executives, and other healthcare providersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 3, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 3, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 30, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 4, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 4, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 15, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 31, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 27, 2018DOCKASSIGNED TO EXAMINER—
Apr 20, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 19, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 13, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance